ArticleOncotarget2017

The anti-neoplastic activity of Vandetanib against high-risk medulloblastoma variants is profoundly enhanced by additional PI3K inhibition.

Rogerio B Craveiro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.